Teva Pharmaceutical Industries (TEVA) Cash from Financing Activities (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) reported Cash from Financing Activities of -$1 million for Q2 2026, compared with $6 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Teva Pharmaceutical Industries' Cash from Financing Activities came in at -$401 million; for FY2025, it came in at -$2.15 billion.
- By year, Cash from Financing Activities came in at -$1.79 billion in FY2024, -$1.91 billion in FY2023, -$1.49 billion in FY2022 and -$2.17 billion in FY2021.
- Five-year quarterly Cash from Financing Activities spans a low of -$1.74 billion in Q1 2025 and a high of $40 million in Q4 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $13 million (Q1 2026), $40 million (Q4 2025) and -$453 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Teva Pharmaceutical Industries | 46.10 Bn | 32.95 Bn | 2.15 Bn | -1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | -453.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | -1.74 Bn |
| Dec 31, 2024 | -674.00 Mn |
| Jun 30, 2024 | -966.00 Mn |
| Mar 31, 2024 | -151.00 Mn |
| Dec 31, 2023 | -576.00 Mn |
| Sep 30, 2023 | -576.00 Mn |
| Jun 30, 2023 | -55.00 Mn |
| Mar 31, 2023 | -706.00 Mn |
| Dec 31, 2022 | -711.00 Mn |
| Sep 30, 2022 | -439.00 Mn |
| Jun 30, 2022 | -338.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | -501.00 Mn |
| Sep 30, 2021 | -1.18 Bn |
| Jun 30, 2021 | -1.00 Mn |
API Access
Teva Pharmaceutical Industries Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();